Author: Shreya Sur | Friday October 18, 2024
The tablet that received the approval is therapeutically equivalent to Wellbutrin SR sustained-release tablets, 100 mg, 150 mg, and 200 mg, by GlaxoSmithKline LLC, an exchange filing said.
www.ndtvprofit.com